The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes
Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard type 1 diabetes treatment resulting in low uptake among countries that do...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/21907 |